BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
0.00%
(0.00) 1D
Nov 19, 4:10:03 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
27.63M
Avg. vol.
11.81M
Volume
2.69M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
27.63M
Avg. vol.
11.81M
Volume
2.69M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Barron's
·
44 minutes ago
Sell the S&P 500 Because the AI Bubble Is About to Burst, Analyst Says. Buy This Instead.
BigGo Finance
·
1 hour ago
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
TradingView
·
2 hours ago
Stock Market Today: Dow, S&P 500 Futures Rise as Wall Street Awaits Anthropic's Listing— PANW, NTES, SLS in Focus
JournalArta
·
38 minutes ago
Stock Market Today: Nasdaq and S&P 500 Futures Rise Ahead of Anthropic Debut
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com